US Patent 9334487 Methods for diagnosing rheumatoid arthritis

Patent 9334487 was granted and assigned to Imperial Innovations on May, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 4 Jan, 2024

"update inverses"

Golden AI

edited on 4 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11862310 Proximity-based mobile-device updates of electronic health records

Edits on 5 Dec, 2023

"Add patent abstract"

Golden AI

edited on 5 Dec, 2023

Edits made to:

Article (+520 characters)

Article

Patent abstract

The present invention relates to methods of diagnosing, prognosing, preventing or delaying onset of or treating rheumatoid arthritis, methods of distinguishing between different types or stages of rheumatoid arthritis, of identifying an individual at risk of developing rheumatoid arthritis, and of monitoring efficacy of a treatment regime in an individual being treated for rheumatoid arthritis, using a citrullinated enolase peptide to detect or capture antibodies associated with rheumatoid arthritis.

Edits on 29 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 29 Sep, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

Andrew Kinloch0

Karin Lundberg0

Patrick Venables0

Edits on 24 May, 2023